Table 1.
Spearman correlations for obesity with inflammation and metabolic variables in the cohort random sample (n=650)
| |
BMI |
Waist |
Insulin |
|||
|---|---|---|---|---|---|---|
| r | P-value | r | P-value | r | P-value | |
| Main exposure variables |
|
|
|
|
|
|
| BMI |
|
|
0.83 |
<0.01 |
0.55 |
<0.01 |
| Waist |
0.83 |
<0.01 |
|
|
0.53 |
<0.01 |
| Insulin |
0.55 |
<0.01 |
0.53 |
<0.01 |
|
|
| Inflammation markers and adipokines |
|
|
|
|
|
|
| Adiponectin, in men |
−0.23 |
<0.01 |
−0.25 |
<0.01 |
−0.30 |
<0.01 |
| Adiponectin, in women |
−0.31 |
<0.01 |
−0.29 |
<0.01 |
−0.46 |
<0.01 |
| C-reactive protein |
0.40 |
<0.01 |
0.36 |
<0.01 |
0.35 |
<0.01 |
| IL-6 |
0.29 |
<0.01 |
0.32 |
<0.01 |
0.19 |
<0.01 |
| Fibrinogen |
0.24 |
<0.01 |
0.22 |
<0.01 |
0.20 |
<0.01 |
| Orosomucoid |
0.32 |
<0.01 |
0.33 |
<0.01 |
0.31 |
<0.01 |
| Sialic acid |
0.19 |
<0.01 |
0.16 |
<0.01 |
0.11 |
0.01 |
| White blood count |
0.07 |
<0.01 |
0.14 |
<0.01 |
0.10 |
<0.01 |
| Complement component 3 |
0.43 |
<0.01 |
0.39 |
<0.01 |
0.46 |
0.06 |
| Oxidized LDL |
0.06 |
0.12 |
0.10 |
0.01 |
0.07 |
0.06 |
| ICAM-1 (ng/mL) |
0.04 |
0.36 |
0.12 |
<0.01 |
0.10 |
0.01 |
| Leptin, in men |
0.64 |
<0.01 |
0.65 |
<0.01 |
0.50 |
<0.01 |
| Leptin, in women |
0.73 |
<0.01 |
0.69 |
<0.01 |
0.65 |
<0.01 |
| Other metabolic variables |
|
|
|
|
|
|
| Non-esterified fatty acids |
0.07 |
0.07 |
0.04 |
0.31 |
−0.01 |
0.75 |
| Systolic blood pressure |
0.24 |
<0.01 |
0.24 |
<0.01 |
0.33 |
<0.01 |
| Diastolic blood pressure |
0.21 |
<0.01 |
0.20 |
<0.01 |
0.27 |
<0.01 |
| Triglycerides |
0.21 |
<0.01 |
0.28 |
<0.01 |
0.30 |
<0.01 |
| HDL-cholesterol, in men |
−0.18 |
0.01 |
−0.26 |
<0.01 |
−0.28 |
<0.01 |
| HDL-cholesterol, in women |
−0.28 |
<0.01 |
−0.32 |
<0.01 |
−0.36 |
<0.01 |
| HOMA-IR |
0.55 |
<0.01 |
0.53 |
<0.01 |
0.99 |
<0.01 |
| Fasting glucose | 0.26 | <0.01 | 0.30 | <0.01 | 0.44 | <0.01 |